- cafead Sep 22, 2022 at 10:23: AM
via New data from Novo Nordisk's Phase IIIa ONWARDS 2 trial studying insulin icodec shows it is effective as a once-weekly treatment for Type 2 diabetes.
Insulin icodec differs from other basal insulin products currently on the market, as they require once-daily injections.
article source
Insulin icodec differs from other basal insulin products currently on the market, as they require once-daily injections.
article source